Form 4: Dexcom EVP Jacob Steven Leach Reports Stock Sale to Cover Tax Obligations

Dexcom's Executive Vice President and Chief Operating Officer, Jacob Steven Leach, reported selling shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On June 10, 2024, Jacob Steven Leach, EVP and Chief Operating Officer of Dexcom Inc., sold 745 shares of common stock at a price of $115.0508 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following the transaction, Leach directly owns 265,577 shares of Dexcom common stock, which includes 54,896 unvested restricted stock units and 145 shares purchased through the Employee Stock Purchase Plan.
• Additionally, Leach indirectly owns 47,296 shares through the Gregg Family Grandchildren's Trust UAD 12/30/2010, where his spouse serves as a trustee.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a routine transaction. The sale was to cover tax obligations, so it doesn't necessarily reflect a change in sentiment about the company's prospects.

Industry Context

This is a routine disclosure related to insider transactions. It is common for executives to sell shares to cover tax obligations when RSUs vest. These transactions are closely monitored by investors for insights into management's perspective on the company's value, although this particular sale is described as non-discretionary.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include restricted stock units (RSUs) that vest over time.
• Similar to executives at companies like Medtronic or Abbott, Dexcom's executives receive RSUs as part of their compensation.
• The practice of selling shares to cover tax obligations upon vesting is a standard practice among executives in publicly traded companies.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided mitigates this concern.
• The impact on employees is likely minimal, as this is a standard executive transaction.

Key Dates